Literature DB >> 7617371

Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System.

I Sivin.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7617371

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  5 in total

Review 1.  Levonorgestrel subdermal implants. Contraception on trial.

Authors:  M L Frank; C DiMaria
Journal:  Drug Saf       Date:  1997-12       Impact factor: 5.606

Review 2.  Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.

Authors:  A J Coukell; J A Balfour
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

Review 3.  Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.

Authors:  Irving Sivin
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

4.  An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device.

Authors:  Reuben M Valenzuela; Ruju Rai; Brian H Kirk; Jessica N Sanders; Subhashree Sundar; Steffen Hamann; Judith E A Warner; Kathleen B Digre; Alison V Crum; Kirtly P Jones; Bradley J Katz
Journal:  Neuroophthalmology       Date:  2017-04-19

5.  Pseudotumor cerebri in a child treated with acitretin: a rare occurrence.

Authors:  Somenath Sarkar; Kapildev Das; Soumyajit Roychoudhury; Arpit Shrimal
Journal:  Indian J Pharmacol       Date:  2013 Jan-Feb       Impact factor: 1.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.